You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Colorcon
AstraZeneca
McKesson
Medtronic

Last Updated: April 1, 2020

DrugPatentWatch Database Preview

Litigation Details for Cephalon Inc. v. Barr Pharmaceuticals Inc. (D. Del. 2008)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Cephalon Inc. v. Barr Pharmaceuticals Inc. (D. Del. 2008)

Docket   Start Trial Date Filed 2008-07-22
Court District Court, D. Delaware Date Terminated 2010-11-15
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties BARR LABORATORIES INC.; BARR PHARMACEUTICALS INC.; CEPHALON INC.; CIMA LABS INC.
Patents 4,671,953; 5,102,665; 5,178,878; 5,234,957; 5,607,697; 6,200,604; 6,264,981; 6,974,590
Attorneys Brian E. Farnan; Douglas Edward McCann; John C. Phillips , Jr.; Keith R. Pozulp; Michael K. Nutter; William J. Marsden , Jr.
Firms Farnan LLP; Phillips, Goldman & Spence, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Cephalon Inc. v. Barr Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Cephalon Inc. v. Barr Pharmaceuticals Inc.
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Cephalon Inc. v. Barr Pharmaceuticals Inc. (D. Del. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-07-22 1 Complaint .... 514/282 4,639,368 A 1/1987 Niazi et al. 4,671,953 A * 6/1987 Stanley et al. .............. 424/440…United States Patent Nos. 6,200,604 Bl (“the ’604 patent”) and 6,974,590 B2 (“the ’590 patent”) under the…prior to patent expiry will infringe the ’604 patent. COUNT II Infringement of the ’604 Patent Under 35…prior to patent expiry Will infringe the ’5 90 patent. COUNT V Infringement of the ’590 Patent Under 35…States Patent Pather et al. US006200604B1 (10) Patent N0.: US 6,200,604 Bl (45) Date of Patent: Mar. External link to document
2008-09-04 10 Answer to Counterclaim United States Patent Nos. 6,200,604 B1 and 6,974,590 B2. D. U.S. Patent No. 6,200,604 B1 … U.S. Patent No. 6,974,590 B2 27. Plaintiffs admit that on its face the ’ 590 patent lists… Plaintiffs admit that on its face the ’ 604 patent lists Sathasivan Indiran Pather, Rajendra K. Khankari…inventors. Plaintiffs admit that on its face the ’ 604 patent lists CIMA Labs Inc. as an assignee. Plaintiffs…rights, title and interest in and to the ’ 604 patent. Plaintiffs admit that Cephalon is the holder of External link to document
2008-07-23 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,200,604; 6,974,590; (ead) (…HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 US 6,200,604 B1 …Laboratories Inc. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office FILING External link to document
2010-11-15 67 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,200,604; US 6,974,590;. (… 15 November 2010 1:08-cv-00455 830 Patent None District Court, D. Delaware External link to document
2008-08-12 8 Answer to Complaint United States Patent Nos. 6,200,604 Bl (“the ‘604 patent”) and 6,974,590 132 (“the ‘59() patent”) under the…United States Patent Nos. 6,200,604 Bl (“the ‘604 patent”) and 6,974,590 132 (“the ‘590 patent”). 12 Case…/2008 Page 13 of 18 D. U.S. Patent No. 6,200,604 Bi 21. The ‘604 patent states on its face that it was…any valid and enforceable claim of U.S. Patent Nos. 6,200,604 Bl and 6,974,590 B2; (c) declaring that…alleged that the claims of the ‘604 patent and the claims of the ‘590 patent would not be infringed by the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Baxter
Colorcon
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.